Unique ID issued by UMIN | UMIN000000526 |
---|---|
Receipt number | R000000638 |
Scientific Title | Establishment of evidences for usage of sedative drugs in neonates and children: Evaluation of the dosage, efficacy, and safety of midazolam. |
Date of disclosure of the study information | 2006/11/22 |
Last modified on | 2009/11/24 10:07:30 |
Establishment of evidences for usage of sedative drugs in neonates and children: Evaluation of the dosage, efficacy, and safety of midazolam.
Evaluation of the dosage, efficacy, and safety of midazolam.
Establishment of evidences for usage of sedative drugs in neonates and children: Evaluation of the dosage, efficacy, and safety of midazolam.
Evaluation of the dosage, efficacy, and safety of midazolam.
Japan |
Mechanically ventilated neonates and children.
Pediatrics |
Others
NO
To evaluate the efficacy, safety, and pharmaco-dynamics of midazolam.
Safety,Efficacy
Phase III
Success rate for sedation with midazolam in evaluating sedative state by Ramsay sedation score
Adverse event/Pharmacokinetics
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Midazolam
Not applicable |
15 | years-old | > |
Male and Female
Mechanically ventilated neonates and children are included:
1) whose post-conceptional age are between 23 weeks and 15 years old,
2) who are obtained informed consent.
Neonates and children are excluded:
1) who are given paralyzing and sedative drugs continuously.
2) who are given the drugs listed on the drugs do not use.
3) who have severe congenital malformation and chromosomal anomaly.
4) who have neurological disease (ex. severe neonatal asphyxia, severe central nerve impairment, and congenital metabolic diseases) by which it is difficult to evaluate the sedative state.
5) who have severe liver dysfunction, or renal dysfunction.
6) who have hyper reactivity to midazolam and other drugs.
7) who have acute glaucoma.
8) who have severe myasthenia gravis.
9) who are given HIV protease inhibitor, or HIV reverse transcriptase inhibitor.
10) who have alcoholism with shock, come, and depressed vital sign.
11) who have already attended to this study.
12) who are diagnosed not suitable for this study by attending doctors because of their psychological or social factors.
13) who are diagnosed not suitable for this study by attending doctors
14) whose parents change their mind and want not to attend to this study afterward.
15) who are given midazolam by bolus intravenous injection only.
75
1st name | |
Middle name | |
Last name | Yushi Itoh ,MD |
National Center for Child Health and Development
Division of Neonatology, Department of Perinatology and Maternal Care.
2-10-1 Okura,Setakgaya-ku tokyo 157-8535 Japan
03-3416-0181
1st name | |
Middle name | |
Last name | Yushi Itoh ,MD |
National Center for Child Health and Development
Division of Neonatology, Department of Perinatology and Maternal Care.
2-10-1 Okura,Setakgaya-ku tokyo 157-8535 Japan
03-3416-0181
Health and Labour Science Research Grants for Clinical Research on Pediatric disease(Evaluation of the dosage, efficacy, and safety of midazolam)study groups.
Health and Labour Science Research Grants for Clinical Research on Pediatric disease
NO
2006 | Year | 11 | Month | 22 | Day |
Unpublished
Completed
2006 | Year | 09 | Month | 03 | Day |
2006 | Year | 11 | Month | 01 | Day |
2009 | Year | 03 | Month | 01 | Day |
2009 | Year | 06 | Month | 01 | Day |
2009 | Year | 09 | Month | 01 | Day |
2009 | Year | 12 | Month | 01 | Day |
2006 | Year | 11 | Month | 22 | Day |
2009 | Year | 11 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000638
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |